These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
524 related articles for article (PubMed ID: 17908964)
1. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Guan Y; Kuo WL; Stilwell JL; Takano H; Lapuk AV; Fridlyand J; Mao JH; Yu M; Miller MA; Santos JL; Kalloger SE; Carlson JW; Ginzinger DG; Celniker SE; Mills GB; Huntsman DG; Gray JW Clin Cancer Res; 2007 Oct; 13(19):5745-55. PubMed ID: 17908964 [TBL] [Abstract][Full Text] [Related]
2. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality. Nagoshi H; Taki T; Hanamura I; Nitta M; Otsuki T; Nishida K; Okuda K; Sakamoto N; Kobayashi S; Yamamoto-Sugitani M; Tsutsumi Y; Kobayashi T; Matsumoto Y; Horiike S; Kuroda J; Taniwaki M Cancer Res; 2012 Oct; 72(19):4954-62. PubMed ID: 22869583 [TBL] [Abstract][Full Text] [Related]
3. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy. Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779 [TBL] [Abstract][Full Text] [Related]
4. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477 [TBL] [Abstract][Full Text] [Related]
5. Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization. Shimada M; Imura J; Kozaki T; Fujimori T; Asakawa S; Shimizu N; Kawaguchi R Oncol Rep; 2005 Apr; 13(4):633-41. PubMed ID: 15756435 [TBL] [Abstract][Full Text] [Related]
6. High amplification of PVT1 and MYC predict favorable prognosis in early ovarian carcinoma. Yamamoto A; Kurata M; Yamamoto K; Nogawa D; Inoue M; Ishibashi S; Ikeda M; Miyasaka N; Kitagawa M Pathol Res Pract; 2020 Nov; 216(11):153175. PubMed ID: 32841774 [TBL] [Abstract][Full Text] [Related]
7. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH. Wang ZR; Liu W; Smith ST; Parrish RS; Young SR Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442 [TBL] [Abstract][Full Text] [Related]
8. Amplification and the clinical significance of circulating cell-free DNA of PVT1 in breast cancer. Li X; Chen W; Wang H; Wei Q; Ding X; Li W Oncol Rep; 2017 Jul; 38(1):465-471. PubMed ID: 28534994 [TBL] [Abstract][Full Text] [Related]
9. Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an Morea A; Saravi S; Sisu C; Hall M; Tosi S; Karteris E; Storlazzi CT Anticancer Res; 2024 May; 44(5):1817-1827. PubMed ID: 38677725 [TBL] [Abstract][Full Text] [Related]
10. Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma. Riquelme E; Suraokar MB; Rodriguez J; Mino B; Lin HY; Rice DC; Tsao A; Wistuba II J Thorac Oncol; 2014 Jul; 9(7):998-1007. PubMed ID: 24926545 [TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients. Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657 [TBL] [Abstract][Full Text] [Related]
12. MYC amplification and polysomy 8 in chondrosarcoma: array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome. Morrison C; Radmacher M; Mohammed N; Suster D; Auer H; Jones S; Riggenbach J; Kelbick N; Bos G; Mayerson J J Clin Oncol; 2005 Dec; 23(36):9369-76. PubMed ID: 16361637 [TBL] [Abstract][Full Text] [Related]
13. Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array. Rummukainen JK; Salminen T; Lundin J; Kytölä S; Joensuu H; Isola JJ Mod Pathol; 2001 Oct; 14(10):1030-5. PubMed ID: 11598174 [TBL] [Abstract][Full Text] [Related]
14. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Agochiya M; Brunton VG; Owens DW; Parkinson EK; Paraskeva C; Keith WN; Frame MC Oncogene; 1999 Oct; 18(41):5646-53. PubMed ID: 10523844 [TBL] [Abstract][Full Text] [Related]
15. Two populations of double minute chromosomes harbor distinct amplicons, the MYC locus at 8q24.2 and a 0.43-Mb region at 14q24.1, in the SW613-S human carcinoma cell line. Guillaud-Bataille M; Brison O; Danglot G; Lavialle C; Raynal B; Lazar V; Dessen P; Bernheim A Cytogenet Genome Res; 2009; 124(1):1-11. PubMed ID: 19372663 [TBL] [Abstract][Full Text] [Related]
16. Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Nupponen NN; Porkka K; Kakkola L; Tanner M; Persson K; Borg A; Isola J; Visakorpi T Am J Pathol; 1999 Jun; 154(6):1777-83. PubMed ID: 10362802 [TBL] [Abstract][Full Text] [Related]
17. Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer. Yasojima H; Shimomura A; Naoi Y; Kishi K; Baba Y; Shimazu K; Nakayama T; Kim SJ; Tamaki Y; Noguchi S Eur J Cancer; 2011 Aug; 47(12):1779-88. PubMed ID: 21741827 [TBL] [Abstract][Full Text] [Related]
18. Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer. Rodriguez V; Chen Y; Elkahloun A; Dutra A; Pak E; Chandrasekharappa S Genes Chromosomes Cancer; 2007 Jul; 46(7):694-707. PubMed ID: 17440925 [TBL] [Abstract][Full Text] [Related]
19. A molecularly genetic determination of prognostic factors of the prostate cancer and their relationships to expression of protein p27kip1. Dvorácková J; Uvírová M Neoplasma; 2007; 54(2):149-54. PubMed ID: 17319789 [TBL] [Abstract][Full Text] [Related]
20. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization. Hara T; Ooi A; Kobayashi M; Mai M; Yanagihara K; Nakanishi I Lab Invest; 1998 Sep; 78(9):1143-53. PubMed ID: 9759658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]